Brian Riesenberg
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Immunology top 10%
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 2
-
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 2
- Co-authors
- Zihai Li (11 shared papers)Bei Liu (8 shared papers)Bill Xingjun Wu (5 shared papers)Alessandra Metelli (5 shared papers)Anqi Li (3 shared papers)Chrystal Mary Paulos (5 shared papers)Mark P. Rubinstein (4 shared papers)Saleh Rachidi (2 shared papers)
- Journals
- Cancer Research (3 papers)Cancer Immunology Research (2 papers)Science Immunology (2 papers)Journal of Clinical Investigation (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesChinaBelgium
In The Last Decade
Brian Riesenberg
21 papers receiving 1.3k citations
Brian Riesenberg's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 496
- Immunology 276
- Hematology 156
- Cancer Research 104
- Cell Biology 97
Countries citing papers authored by Brian Riesenberg
This map shows the geographic impact of Brian Riesenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Riesenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Riesenberg more than expected).
Fields of papers citing papers by Brian Riesenberg
This network shows the impact of papers produced by Brian Riesenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Riesenberg. The network helps show where Brian Riesenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Riesenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 295 | |
| 2 | 2022 | 166 | |
| 3 | 2020 | 112 | |
| 4 | 2020 | 102 | |
| 5 | Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment Hit paper breakdown → | 2024 | 86 |
| 6 | 2016 | 81 | |
| 7 | 2017 | 61 | |
| 8 | 2019 | 53 | |
| 9 | 2019 | 39 | |
| 10 | 2017 | 38 | |
| 11 | 2020 | 38 | |
| 12 | 2021 | 35 | |
| 13 | 2022 | 34 | |
| 14 | 2022 | 25 | |
| 15 | 2015 | 22 | |
| 16 | 2025 | 22 | |
| 17 | 2022 | 18 | |
| 18 | 2019 | 15 | |
| 19 | 2025 | 11 | |
| 20 | 2018 | 8 |
About Brian Riesenberg
Brian Riesenberg is a scholar working on Oncology, Immunology, Cell Biology, Sensory Systems and Molecular Biology, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), T-cell and B-cell Immunology (6 papers), Endoplasmic Reticulum Stress and Disease (3 papers), TGF-β signaling in diseases (2 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), RNA and protein synthesis mechanisms (1 paper) and Heat shock proteins research (1 paper). The work is most often cited by research in Oncology (496 citations), Immunology (276 citations), Hematology (156 citations), Cancer Research (104 citations) and Cell Biology (97 citations). Brian Riesenberg has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Zihai Li, Bei Liu, Bill Xingjun Wu, Alessandra Metelli, Anqi Li, Chrystal Mary Paulos, Mark P. Rubinstein, Saleh Rachidi, No‐Joon Song and Yi Yang. Their work appears in journals such as Cancer Research, Cancer Immunology Research, Science Immunology, Journal of Clinical Investigation and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.